CURE®'s 20th Anniversary Celebration

Patrick Dempsey Notes Mental Health in Cancer Care Has ‘Changed Tremendously’ Over Past 2 Decades

May 5th 2022

Mental wellbeing is more of a focus than ever before in cancer care, and while treatments continue to get better, there is still a long road ahead, according to Patrick Dempsey.

More Research Efforts Needed to Ensure Kidney Cancer Treatments ‘Get Smarter’ to Limit Side Effects, Expert Says

April 22nd 2022

An expert discusses the side effects patients with kidney cancer may experience from immunotherapy and tyrosine kinase inhibitor treatment, and how more research is needed in to ensure patients experience less side effects.

Targeted Therapy Advances in Lung Cancer Space Over Past 2 Decades 'Simply Remarkable'

April 14th 2022

Over the past 20 years, advancements in the lung cancer space have led to a drastic paradigm shift in how patients are now treated, ultimately leading to substantial improvements in survival and patient quality of life.

‘Monumental’ Treatment Advancements Have Been ‘Life-Changing’ For Many Patients With Thyroid Cancer

April 5th 2022

Monumental treatment advancements over the past two decades have given patients with thyroid cancer the ability to live longer and better lives, according to an expert from Cleveland Clinic’s Taussig Cancer Institute. However, more work is needed to find curative treatments.

The Changing Landscape of Colorectal Cancer Treatment Opens the Door to More Precise Techniques, Higher Survivorship Rates

March 29th 2022

Twenty years of updates in technology, techniques and available medications has provided more hope for patients with colorectal cancer, with more advances on the horizon.

Personalized Treatment Advanced the Field and Decreased Side Effects in Head and Neck Cancer

March 24th 2022

Over the last 20 years, head and neck cancer treatment moved away from aggressive treatments for all patients to a more personalized approach — improving both outcomes and quality of life for patients with the disease.

20 Years of Advancements Brings a 'Luxury' of Treatment Options for Patients With Myeloma

March 21st 2022

In honor of CURE®’s 20th anniversary, we spoke with experts on how the past 20 years have revolutionized multiple myeloma treatment.

Decades' Worth of Reconstruction Advancements Have Transformed the Lives of Many Patients Who Underwent Debilitating Cancer Treatments

March 10th 2022

Aesthetic appearances, according to an expert at the UCSF, are often important for patients following the surgical treatment of cancer. Advancements in this space over the past 20 years have allowed many to patients to look as normal as possible.

Addressing Psychosocial Needs in Cancer Care Has Improved Over Past 20 Years, But More Work Still Needed

March 7th 2022

Increased resources and technological advances have allowed cancer survivors experiencing psychological side effects to seek help that might not have been available to them 20 years ago.

Advancements in Rare Blood Cancer Have ‘Changed the Way We Treat Every Cancer’, Expert Says

February 11th 2022

A blood cancer specialist discusses how the development of tyrosine kinase inhibitors in the 1990s to treat chronic myelogenous leukemia drove major oncology advancements over the next three decades.

Progress in LGBTQ Cancer Care Over Past 2 Decades Has Been ‘Steady But Absolutely Pronounced,’ With More Advancements Needed

February 9th 2022

The executive director of the National LGBT Cancer Network discussed the past two decades of positive change in LGBTQ cancer care and highlighted what more still needs to be done.

I Didn’t Think I Would Be Strong Enough to Survive Cancer 20 Years Ago, But I Was so Wrong

February 1st 2022

A woman with metastatic breast cancer reflects on her pre-cancer life 20 years ago and how her perspective on the disease has shifted as she’s reached a level of acceptance and hope for the future.

VHL-Related Kidney Cancer Survivor Reflects on Decades of Change for the Rare Condition

January 24th 2022

When Joseph Heisler was diagnosed with von Hippel-Lindau disease 30 years ago, there was hardly any information on the condition. Fast forward three decades, there is an FDA-approved drug and a handbook of information available in two languages.